RESEARCH PAPER
Assessment of adequacy of vitamin D supplementation during pregnancy
 
More details
Hide details
1
Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
2
Department of Endocrinology and Metabolic Diseases, Medical University, Lodz, Poland
 
Ann Agric Environ Med. 2014;21(1):198–200
KEYWORDS
ABSTRACT
Introduction:
Deficiency of vitamin D in pregnancy leads to higher incidences of preeclampsia, gestational diabetes, preterm birth, bacterial vaginosis, and also affects the health of the infants. According to Polish recommendations published in 2009, vitamin D supplementation in pregnant women should be provided from the 2nd trimester of pregnancy in daily dose of 800–1000 IU. The aim of the presented study is: 1) to estimate how many pregnant women comply with those recommendations and 2) to determine the 25(OH)D levels in pregnant women.

Patients and methods:
The study included 88 pregnant women, aged 20–40 years, between 12–35 week of gestation. Vitamin D concentrations [25(OH)D] were measured by a direct electrochemiluminescence immunoassay (Elecsys, Roche).

Results:
31 of 88 pregnant women (35.2%) did not use any supplementation. Mean level of 25(OH)D was 28.8±14.8 ng/mL (range from 4.0 – 77.5 ng/mL). Vitamin D deficiency, defined as 25(OH)D concentration below 20 ng/mL, was found in 31.8% of the women (28/88). Insufficiency of vitamin D [25(OH)D concentration between 20–30 ng/mL] was present in 26.1% of the women (23/88). Optimal level of 25(OH)D (over 30 ng/mL) was present in 37/88 (42.0% women). Hence, in 46.2% of women taking vitamin D supplementation, the levels of 25(OH)D were still below 30 ng/mL.

Conclusions:
Supplementation of vitamin D in the investigated group was inadequate. More than 35% of pregnant women did not take any supplements, while half of the subjects who had declared taking vitamin D, failed to achieve optimal serum 25(OH)D concentration.

 
REFERENCES (21)
1.
Holick MF: Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009; 19: 73–78.
 
2.
Bikle D Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009; 94: 26–34.
 
3.
Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011; 86: 50–60.
 
4.
Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placentaldecidual function. J Soc Gynecol Investig. 2004; 11: 263–271.
 
5.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007; 92: 3517–3522.
 
6.
Møller UK, Streym S, Heickendorff L, Mosekilde L, Rejnmark L Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr. 2012; 66: 862–868.
 
7.
Senti J, Thiele DK, Anderson CM. Maternal vitamin d status as a critical determinant in gestational diabetes. J Obstet Gynecol Neonatal Nurs. 2012; 41: 328–338.
 
8.
Bodnar LM, Krohn MA, Simhan HN Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 2009; 139: 1157–1161.
 
9.
Zeghoud F, Vervel C, Guillozo H, Walrant-Debray O, Boutignon H, Garabedian M. Subclinical vitamin D deficiency in neonates: definition and response to vitamin D supplements. Am J Clin Nutr. 1997; 65: 771–778.
 
10.
Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011; 127: e180-e187.
 
11.
Hypponen E, Laara E, Reunanen A, Jarvelin M, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500–1503.
 
12.
McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Jarvelin MR et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res. 2004; 67: 237–245.
 
13.
Pawley N, Bishop NJ Prenatal and infant predictors of bone health: the influence of vitamin D Am J Clin Nutr. 2004; 80 (suppl): 1748S–1751S.
 
14.
Krenz-Niedbała M, Puch EA, Kościński K. Season of birth and subsequent body size: the potential role of prenatal vitamin D. Am J Hum Biol. 2011; 23: 190–200.
 
15.
Charzewska J, Chlebna-Sokół D, Chybicka A, Czech-Kowalska J, Dobrzańska A, Helwich E et al. Prophylaxis of vitamin D deficiency – Polish recommendation 2009 [in Polish]. Ginekol Pol. 2010; 81: 149–153.
 
16.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911–1930.
 
17.
Bojar I, Owoc A, Humeniuk E, Wierzba W, Fronczak A. Inappropriate consumption of vitamins and minerals by pregnant women in Poland. Ann Agric Environ Med. 2012;19: 263–266.
 
18.
Bruyère O, Malaise O, Neuprez A, Collette J, Reginster JY. Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin. 2007; 23: 1939–1944.
 
19.
Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: A National Cross-Sectional Survey. PLoS ONE 2012; 7(8): e43868. doi:10.1371/ journal.pone.0043868.
 
20.
Thomas SD, Fudge AN, Whiting M, Coates PS. The correlation between third-trimester maternal and newborn-serum 25-hydroxy-vitamin D in a selected South Australian group of newborn samples. British Med J Open 2011; 1: e000236.
 
21.
Li W, Green TJ, Innis SM, Barr SI, Whiting SJ, Shand A et al. Suboptimal vitamin D levels in pregnant women despite supplement use. Can J Public Health 2011; 102: 308–312.
 
eISSN:1898-2263
ISSN:1232-1966